thiazolidines has been researched along with Kidney Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, YC; Jang, BC; Jang, JH; Kim, DE; Kim, KH; Kim, S; Kwon, TK; Lee, J; Lee, KS; Park, JS; Park, JW | 1 |
1 other study(ies) available for thiazolidines and Kidney Neoplasms
Article | Year |
---|---|
BAI, a novel Cdk inhibitor, enhances farnesyltransferase inhibitor LB42708-mediated apoptosis in renal carcinoma cells through the downregulation of Bcl-2 and c-FLIPĀ (L).
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Membrane Potential, Mitochondrial; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Thiazolidines | 2014 |